SCHEMBL18488361

SCHEMBL18488361

CCc1ncc(Cl)c(NCCc2ccccc2)n1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 2/20 0.49
CYP2C19 P33261 2/20 0.49
CYP1A2 P05177 1/20 0.49
CYP3A4 P08684 1/20 0.49
APP P05067 6/20 0.48
METAP2 P50579 1/20 0.45
METAP1 P53582 1/20 0.45
BCHE P06276 4/20 0.45
ACHE P22303 4/20 0.45
SLC29A1 Q99808 1/20 0.45
TP53 P04637 1/20 0.43
MAPT P10636 1/20 0.43
TMIGD3 P0DMS9 2/20 0.43
ADORA2A P29274 2/20 0.43
ADORA2B P29275 2/20 0.43
ADORA1 P30542 2/20 0.43
MAPK1 P28482 2/20 0.43
HTT P42858 2/20 0.43
CYP2C9 P11712 1/20 0.43
TSHR P16473 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18488676 0.85 TAAR1 (0.46) HTTNPC1RAB9ALMNATAAR1
SCHEMBL24255306 0.83 APP (0.50) CYP2D6CYP2C19CYP1A2CYP3A4APP
SCHEMBL18488975 0.83 PGK1 (0.48) CYP2C19CYP1A2APPMAPK1HTT
SCHEMBL18488360 0.82 APP (0.60) CYP2D6CYP2C19CYP1A2CYP3A4APP
SCHEMBL29555879 0.82 APP (0.60) CYP2D6CYP2C19CYP1A2CYP3A4APP
SCHEMBL18488334 0.77 GPR84 (0.42) TAAR1STK17BSTK17A
SCHEMBL18488674 0.75 CTSC (0.48) CYP2D6CYP2C19CYP1A2TP53MAPT
SCHEMBL18488673 0.74 APP (0.50) CYP2D6CYP2C19CYP1A2CYP3A4APP
SCHEMBL21460559 0.71 APP (0.57) CYP2D6CYP2C19CYP1A2CYP3A4APP
SCHEMBL11103596 0.71 HTT (0.55) APPSLC29A1MAPTTMIGD3ADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017023899-A1 INHIBITORS OF ACK1/TNK2 TYROSINE KINASE H. LEE MOFFITT CANCER CENTER & RESEARCH INSTITUTE (US) 2017-02-09 WO disclosed